BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6308965)

  • 1. Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy.
    Friis H; Hoffmann S; Hansen M; Hansen MM; Justesen T; Nissen NI
    Acta Med Scand; 1983; 213(5):345-9. PubMed ID: 6308965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
    J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis.
    Hall MA; Ducker DA; Lowes JA; McMichael J; Clarke P; Rowe D; Gordon A; Cole DS
    Drugs; 1988; 35 Suppl 2():169-77. PubMed ID: 3293973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
    Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
    Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime as first-line therapy for fever in acute leukaemia.
    Donnelly JP; Marcus RE; Goldman JM; Cohen J; Worsley AM; Catovsky D; Darrell JH; Want SV; Galton DA
    J Infect; 1985 Nov; 11(3):205-15. PubMed ID: 3910730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
    Chan CC; Oppenheim BA; Anderson H; Swindell R; Scarffe JH
    Antimicrob Agents Chemother; 1989 Jan; 33(1):87-91. PubMed ID: 2653217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of serious urological infections with cefotaxime compared to ampicillin plus netilmicin.
    Rasmussen D; Bremmelgaard A; Rasmussen F; Thorup J
    Dan Med Bull; 1986 Feb; 33(1):49-51. PubMed ID: 3948539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 9. A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis.
    Sage R; Nazareth B; Noone P
    Scand J Infect Dis; 1987; 19(3):331-7. PubMed ID: 3616496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
    Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
    Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First-line treatment of febrile episodes in leukemia in adults. Randomized, multicenter study of ceftazidime in single antibiotic therapy versus a cefotaxime-amikacin combination].
    Piguet H; Pappo M
    Presse Med; 1988 Oct; 17(37):1954-9. PubMed ID: 2973595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients.
    Palmblad J; Lönnqvist B
    Acta Med Scand; 1982; 212(6):379-84. PubMed ID: 6760676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics in febrile neutropenia: a randomized prospective comparison of two combinations.
    Madiajagane R; Maitreyan V; Sagar TG; Shanta V
    Natl Med J India; 1993; 6(2):67-70. PubMed ID: 8477212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients.
    Herbrecht R; Damonte JC; Bergerat JP; Jehl F; Liu KL; Prevost G; Dufour P; Duclos B; Oberling F
    Infection; 1990; 18(5):310-3. PubMed ID: 2276828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
    Johnson PR; Liu Yin JA; Tooth JA
    J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results.
    Hellriegel KP; Kindler J; Wittenberg C; Kress M
    Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study of cefotaxime in patients with infections complicating a disorder of the hemopoietic tissue. Its therapeutic effect and influence on the coagulation system].
    Kaneko H; Shirai T; Katoh M; Shimura H; Nojima Z; Senzui N
    Jpn J Antibiot; 1985 Nov; 38(11):3145-55. PubMed ID: 4094050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D; Bacci S; Bosi A; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi Ferrini P
    J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.